Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03604367 · ClinicalTrials.gov registry record

Gait Mate: Examining Neural Networks Engaged During Lower Extremity Movement in the MRI

A clinical trial, sponsored by Medical University of South Carolina.

Completed
Registry status
21
Enrollment target

NCT03604367: Completed study, sponsored by Medical University of South Carolina.

NCT03604367 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03604367 has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
21 participants
Enrollment target

Study Summary

Less than 50% of stroke survivors progress to independent community ambulation. Even among the stroke survivors who achieve independent ambulation, significant residual deficits persist in balance and gait speed, with 60% of persons post-stroke reporting limitations in mobility related to walking.Consequently maximizing recovery of locomotor function is the focus of neurorehabilitation efforts worldwide. A recently completed clinical trial from members of this investigative team demonstrated that 6 weeks of treadmill training elicits substantial improvements in over ground walking speed and symmetry in persons following stroke. Consistent with the goals of the South Carolina Stroke Rehabilitation Research Center (SCSRRC) and NIH Brain Initiative, the investigators now plan to investigate the effects treadmill-assisted gait training have on cortical control of bipedal movement in chronic stroke patients. Although previous investigators have assessed neural activity during simulated walking using motor imagery, motor imagery does not simulate the typical sensory feedback associated with active movement. To move the field forward, it is necessary to measure active bipedal movement in the MR-environment in healthy volunteers, before moving forward in stroke patients.

Primary Outcome

Determine if the bipedal fMRI protocol (active movement) is able to engage neural networks more robustly (e.g. greater effect size) than bipedal imagery alone in healthy volunteers.

Interventions

  • DEVICE GAITRite assessment

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2018-02-01
Est. Completion 2019-06-14

What the finished NCT03604367 record still lists

NCT03604367 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which GAITRite assessment is the first listed.

NCT03604367 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03604367 about?

NCT03604367 is a clinical study titled "Gait Mate: Examining Neural Networks Engaged During Lower Extremity Movement in the MRI". Less than 50% of stroke survivors progress to independent community ambulation. Even among the stroke survivors who achieve independent ambulation, significant residual deficits persist in balance and gait speed, with 60% of persons post-stroke reporting limitations in mobility related to walking.Co...

What is the current status of trial NCT03604367?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2018-02-01. Estimated completion is 2019-06-14.

What interventions are being tested in trial NCT03604367?

The interventions under investigation include: GAITRite assessment (DEVICE).

Who is sponsoring clinical trial NCT03604367?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03604367, the US trial registry maintained by the National Library of Medicine. NCT03604367 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.